colorectal Archives - AudioMedica.com

Tagged: colorectal

0
- in Oncology
- — 25 May, 2008
Audio Journal of Oncology Volume 16 Number 10
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin
In this edition Peter Goodwin and Sara Freeman report from:
European Breast Cancer Conference, Berlin, April 15-19, 2008;
Chemotherapy …
Read more
0
- in Oncology
- — 15 Feb, 2008
Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

David Cunningham
REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
DAVID CUNNINGHAM, Royal Marsden Hospital, London
The oral agent capeticabine is just as effective as fluorouracil for treating patients whose metastatic colorectal cancer
…
Read more
0
- in Oncology
- — 27 Jan, 2008
Gastrointestinal Cancers: Progress with Targeted Therapies

Robert Mayer
ROBERT MAYER, Dana-Farber Cancer Institute, Boston
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and
…
Read more
0
- in Oncology
- — 16 Oct, 2007
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Jose Baselga

Gordon McVie
REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
Neoadjuvant trastuzumab for patients with HER2-positive
…
Read more
0
- in Oncology
- — 26 Sep, 2007
Laparoscopic-Assisted Resection for Colorectal Cancer

Pierre Guillou

David Jayne
REFERENCE: J Clin Oncol 25:3061-3068
PIERRE GUILLOU, St James’ Hospital, Leeds
COMMENT: DAVID JAYNE, St James’ Hospital, Leeds
Laparoscopic-assisted resection for colorectal cancer has proved just as effective as conventional open surgery, according to researchers in
…
Read more
0
- in Oncology
- — 31 Aug, 2007
KRAS Mutation: Powerful Molecular Predictor of Cetuximab Response in Patients With Metastatic Colorectal Cancer

Pierre Laurent-Puig

Bill Hait
REFERENCE: ABSTRACT: 5671, American Association for Cancer Research, April 14-18, 2007, Los Angeles
PIERRE LAURENT-PUIG, Hôpital Européen Georges Pompidou, Paris
COMMENT: BILL HAIT, Johnson & Johnson, Raritan, NJ
The presence of the KRAS mutation in tumor
…
Read more

in ASCO · Oncology
— 16 May, 2007

Audio Journal of Oncology in Advance – May 15th, 2007 – reporting from: American Association for Cancer Research, April 14-18, 2007, Los Angeles, CA

Alberto Sobrero

Cetuximab With Irinotecan: Phase III Study Shows Benefit in Patients with Oxaliplatin-Refractory Colorectal Cancer

REFERENCE: ABSTRACT LB-2; AACR 2007, Los Angeles, Plenary Session
ALBERTO SOBRERO, Ospedale San Martino, Genoa
Cetuximab could become a mainstay of treatment for colorectal

…

in ASCO · Oncology
— 1 Nov, 2006

Audio Journal of Oncology in Advance – November 1st, 2006

David Cameron

Martine Piccart

Eric Van Cutsem

Jim Cassidy

Volker Heinemann

Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre-treated with Chemotherapy and Trastuzumab

REFERENCE: ESMO 2006, Abstract: 141O
David Cameron, Western General Hospital, Edinburgh
COMMENT: Martine Piccart, Jules

…

in AJO · Oncology
— 1 Oct, 2006

Audio Journal of Oncology in Advance – October 1st, 2006

George Canellos

Sandra Strauss

Nancy Baxter

KIT Mutations in Acute Myeloid Leukemia Confer Higher Relapse Risk
Liver Metastasis Resection Not Curative for Colorectal Cancer
Patients With Node Negative Breast Cancer: Low Risk After Mastectomy

REFERENCES: J Clin Oncol 34:3904, 3927,

…

Tagged: colorectal

Cetuximab With Irinotecan: Phase III Study Shows Benefit in Patients with Oxaliplatin-Refractory Colorectal Cancer

Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre-treated with Chemotherapy and Trastuzumab

KIT Mutations in Acute Myeloid Leukemia Confer Higher Relapse Risk Liver Metastasis Resection Not Curative for Colorectal Cancer Patients With Node Negative Breast Cancer: Low Risk After Mastectomy

Sign up for AudioMedica.com news

KIT Mutations in Acute Myeloid Leukemia Confer Higher Relapse Risk
Liver Metastasis Resection Not Curative for Colorectal Cancer
Patients With Node Negative Breast Cancer: Low Risk After Mastectomy